For resistant breast cancers, two drugs may be better than one

Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research. When these cells are confronted with potent new drugs called CDK2 inhibitors, which are designed to prevent cancer from proliferating, they can trigger a workaround to survive the assault in as little as one to two hours.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news